FOXF2 and lung carcinoma: Although there was no difference in stage II and III groups, in the stage I group FOXF2 expression significantly affected the survival time of lung cancer patients and the FOXF2low group had a significantly lower survival time than the FOXF2high group (P =0.002, Figure 2D).